Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 3, 2021
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
Lara Diem, Christoph Friedli, Andrew Chan, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
CNS Neuroscience & Therapeutics
|
April 12, 2022
Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Robert Hoepner, Christian P Kamm, Christoph Friedli, et al.
Therapeutische Umschau. Revue Therapeutique
|
May 18, 2022
[Primary CNS Vasculitis - An Overview]
Helly Hammer, Nicole Kamber, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders
|
May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
Myriam Briner, Maud Bagnoud, Andrei Miclea, et al.
Therapeutic Advances in Neurological Disorders
|
August 5, 2021
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
Panagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, et al.
CNS Neuroscience & Therapeutics
|
December 8, 2022
Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophy
Michael Rebsamen, Christoph Friedli, Piotr Radojewski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 16, 2022
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients
Christoph Friedli, Franca Wagner, Helly Noemi Hammer, et al.
Cureus
|
August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study
Lara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Therapeutic Advances in Neurological Disorders
|
May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
Christoph Friedli, Lara Diem, Helly Hammer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 3, 2021
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
Lara Diem, Christoph Friedli, Andrew Chan, et al.
CNS Neuroscience & Therapeutics
|
January 21, 2022
Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort
Maximilian Pistor, Helly Hammer, Anke Salmen, et al.
CNS Neuroscience & Therapeutics
|
April 12, 2022
Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
Robert Hoepner, Christian P Kamm, Christoph Friedli, et al.
Therapeutische Umschau. Revue Therapeutique
|
May 18, 2022
[Primary CNS Vasculitis - An Overview]
Helly Hammer, Nicole Kamber, Christoph Friedli, et al.
Therapeutic Advances in Neurological Disorders
|
May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
Myriam Briner, Maud Bagnoud, Andrei Miclea, et al.
Therapeutic Advances in Neurological Disorders
|
August 5, 2021
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
Panagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, et al.
CNS Neuroscience & Therapeutics
|
December 8, 2022
Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophy
Michael Rebsamen, Christoph Friedli, Piotr Radojewski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 16, 2022
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients
Christoph Friedli, Franca Wagner, Helly Noemi Hammer, et al.
Cureus
|
August 18, 2025
Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study
Lara Diem, Simona Daepp, Vincenzo P Introcaso, et al.
Therapeutic Advances in Neurological Disorders
|
May 28, 2021
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
Christoph Friedli, Lara Diem, Helly Hammer, et al.
Page
of 3